Mitochondrial Markers: What They Can and Cannot Tell You

Mitochondrial markers are lab measures used to study or evaluate mitochondrial function, stress, or damage. In people, commonly discussed blood markers include lactate, pyruvate, alanine, GDF15, and FGF21, but none can diagnose mitochondrial disease alone. Results need clinical context, and longevity-related claims remain limited by human evidence.

What are mitochondrial markers?

Mitochondrial markers are clues that may reflect how mitochondria are making energy, handling stress, or being damaged. They can be measured in blood, urine, tissue, or cells, but each marker has limits and must be read with the patient’s symptoms and exam findings 1.

The two meanings: clinical biomarkers versus research marker antibodies

Patients often see two different uses of the phrase. Clinical mitochondrial biomarkers include blood or urine tests such as lactate, pyruvate, alanine, fibroblast growth factor 21 (FGF21), and growth differentiation factor 15 (GDF15), which may help guide further evaluation 1. Mitochondrial marker antibodies are different: they are lab tools used in immunofluorescence, western blot, flow cytometry, and related research methods to identify mitochondrial proteins in cells or tissue 2.

Why mitochondria matter for energy, signaling, and cell stress

Mitochondria make most cellular ATP through oxidative phosphorylation, a process that uses the electron transport chain inside the inner mitochondrial membrane. Mitochondria also help regulate cell signaling, calcium balance, cell death, and stress responses, which is why mitochondrial dysfunction can affect many organs 3.

Quick facts about mitochondrial markers

Mitochondrial testing is usually a stepwise process, not a single blood draw. A clinician may combine symptoms, family history, basic labs, specialized metabolic tests, genetic testing, and sometimes tissue testing when the concern is high 4.

Common blood markers discussed in mitochondrial dysfunction

A systematic review of blood biomarkers for mitochondrial dysfunction found that lactate, pyruvate, FGF21, and GDF15 are among the most studied markers, but their clinical usefulness varies by patient group and study design 1. That is why a result may be a clue, not a conclusion.

What markers can suggest versus what they cannot prove

A marker can suggest that energy metabolism is stressed or that a mitochondrial disorder belongs on the differential diagnosis. It cannot prove the cause, predict lifespan, or replace a full medical evaluation 1.

When a clinician may consider more specialized testing

More specialized testing may be considered when symptoms involve multiple systems, start early in life, worsen with illness or fasting, or match a known mitochondrial syndrome. Consensus guidance supports using clinical findings, biochemical testing, molecular genetic testing, and specialist input together 4.

Which blood markers are used to assess mitochondrial dysfunction?

Blood biomarkers can help frame the question, but they are imperfect. The most useful result is often a pattern across symptoms, labs, and family history rather than one isolated number 1.

Lactate and pyruvate

Lactate and pyruvate are linked to how cells process fuel when oxidative phosphorylation is limited. In suspected mitochondrial disease, clinicians may look at both values and the lactate-to-pyruvate ratio, but false positives can happen if the sample is hard to draw, delayed, or collected after recent exertion 1.

Alanine and related metabolic markers

Alanine can rise when pyruvate is converted into alanine, which may happen in some disorders of energy metabolism. Acylcarnitines and urine organic acids may also show metabolic stress patterns, but these tests are not specific for one mitochondrial diagnosis 4.

FGF21 and GDF15

FGF21 and GDF15 are stress-signaling proteins that have been studied as blood biomarkers in mitochondrial disease. Human studies suggest they may help in some settings, especially certain muscle-involving mitochondrial disorders, but systematic reviews show that marker performance varies and does not replace genetic diagnosis 1.

Creatine kinase and other nonspecific markers

Creatine kinase can rise when muscle is injured, inflamed, or stressed. It may be part of a workup for weakness or exercise intolerance, but it is not a mitochondrial-specific marker because many muscle and medication-related problems can raise it 4.

How do doctors test mitochondria?

Mitochondrial evaluation usually starts with the story: symptoms, timing, triggers, family history, and exam. Testing then moves from broad labs to genetic or specialist testing when the concern remains high 4.

1. 1Medical history and exam: symptoms across muscle, brain, heart, endocrine, eye, hearing, liver, and gastrointestinal systems are reviewed.
2. 2Blood and urine testing: lactate, pyruvate, amino acids such as alanine, acylcarnitines, urine organic acids, liver tests, kidney tests, thyroid tests, and creatine kinase may be considered.
3. 3Genetic testing: mitochondrial DNA and nuclear DNA testing can identify many primary mitochondrial disorders because mitochondria depend on genes from both genomes.
4. 4Specialist evaluation: neurology, genetics, cardiology, ophthalmology, or metabolic specialists may be involved depending on symptoms.
5. 5Muscle biopsy or respiratory chain testing: these are now used more selectively, especially when genetic testing is unclear or tissue-specific disease is suspected.

Modern reviews emphasize that next-generation sequencing has changed mitochondrial diagnosis because pathogenic variants may be in mitochondrial DNA or nuclear genes that affect mitochondrial proteins 5. Muscle biopsy and respiratory chain enzyme testing can still help in select cases, but they are not the first step for every patient 4.

What symptoms can point to mitochondrial disease?

Mitochondrial disease symptoms vary because different tissues need different amounts of energy. Brain, muscle, heart, nerves, eyes, ears, endocrine organs, and the liver can all be involved 6.

Fatigue, exercise intolerance, and muscle weakness

Common clues include severe fatigue, exercise intolerance, muscle weakness, muscle pain, or episodes of worsening after illness. These symptoms are real but nonspecific, so clinicians also look for patterns such as multi-organ involvement, early onset, maternal inheritance, or repeated metabolic crises 6.

Neurologic, heart, endocrine, and vision or hearing findings

Some mitochondrial disorders can include seizures, stroke-like episodes, migraine-like headaches, neuropathy, cardiomyopathy, diabetes, short stature, hearing loss, or optic nerve disease. GeneReviews and consensus statements describe this multi-system pattern as a key reason diagnosis can be complex 4, 6.

Why symptoms vary so much between people

Symptoms vary because mitochondria are influenced by mitochondrial DNA, nuclear DNA, tissue energy needs, age, and heteroplasmy, which means a person can have a mix of normal and abnormal mitochondrial DNA in different tissues. This helps explain why two people with related variants can have different symptoms 5.

What diseases are linked to mitochondrial markers or antibodies?

Mitochondrial markers and antibodies point to different medical questions. Biomarkers may support evaluation for mitochondrial dysfunction, while antimitochondrial antibodies are mainly used in autoimmune liver disease evaluation 1, 7.

Primary mitochondrial disorders

Primary mitochondrial disorders are caused by pathogenic variants in mitochondrial DNA or nuclear DNA genes that affect mitochondrial function. Examples include MELAS, MERRF, Leber hereditary optic neuropathy (LHON), and mitochondrial DNA depletion syndromes 5, 6.

Secondary mitochondrial dysfunction in common diseases

Secondary mitochondrial dysfunction means mitochondria are affected by another condition, exposure, inflammation, medication, or aging process rather than a primary inherited mitochondrial disorder. Researchers study secondary mitochondrial changes in many common diseases, but a biomarker change does not prove that mitochondria are the root cause 3.

Antimitochondrial antibodies and autoimmune liver disease

Antimitochondrial antibodies are blood autoantibodies strongly linked with primary biliary cholangitis, an autoimmune cholestatic liver disease. Liver society guidance uses these antibodies, liver enzyme patterns, and clinical findings in diagnosis 7.

Why antibody tests and mitochondrial marker antibodies are not the same thing

Mitochondrial marker antibodies sold for laboratory research are designed to bind mitochondrial proteins so scientists can see or measure mitochondria in cells or tissue. Antimitochondrial antibodies in a patient’s blood are immune-system signals used in clinical liver evaluation, so the terms should not be mixed 2, 7.

What is the most common mitochondrial disorder?

The most common mitochondrial disorder depends on what definition is used. Some estimates count all pathogenic mitochondrial DNA variants, while others count only people with diagnosed clinical disease 8.

Why prevalence depends on the definition used

Population studies have found that pathogenic mitochondrial DNA variants are more common than diagnosed mitochondrial disease, because not everyone with a variant develops the same symptoms. One widely cited epidemiology study estimated adult mitochondrial DNA disease prevalence at about 9.2 per 100,000, with higher prevalence when including at-risk relatives 8.

Examples patients may hear about, including MELAS, MERRF, LHON, and mitochondrial depletion syndromes

MELAS involves mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. MERRF involves myoclonic epilepsy with ragged-red fibers. LHON mainly affects the optic nerve and can cause sudden vision loss, while mitochondrial DNA depletion syndromes reduce mitochondrial DNA copy number in affected tissues 5, 6.

What do mitochondrial markers mean for longevity research?

Mitochondrial markers in longevity research are tools for studying biology, not proof of longer life. They can help researchers measure energy metabolism, oxidative stress, inflammation, and cell stress pathways, but human lifespan claims require direct human outcome evidence 9.

Human clinical evidence versus observational, animal, and cell evidence

• Human clinical evidence tests an intervention in people and may measure symptoms, function, safety, or biomarkers.
• Human observational evidence can link mitochondrial markers with age, disease, or risk, but it cannot prove cause and effect.
• Animal evidence can show mechanisms in living systems, but it does not prove the same outcome in humans.
• Cell evidence can identify pathways, but it is the earliest level of evidence and cannot predict whole-person benefits by itself.

Biomarkers are not proof of longer human lifespan

A treatment may change a biomarker without changing how long people live or how well they function. Reviews of aging biology describe mitochondrial dysfunction as one hallmark of aging, but hallmarks are research frameworks, not validated treatment targets that prove lifespan extension 9.

How researchers use mitochondrial markers to study aging biology

Researchers use mitochondrial markers to study ATP production, electron transport chain activity, oxidative stress, mitochondrial DNA damage, mitophagy, and stress signaling. If you want a broader foundation, our guides to improving mitochondrial function, mitochondrial boosters, and mitochondrial fatigue explain what is known and what remains experimental.

Mitochondrial health and longevity care at Chia: what is and is not offered

At Chia, we offer clinician-reviewed longevity care, not stand-alone mitochondrial diagnosis or mitochondrial marker testing. Our role is to evaluate health goals, medical history, medications, and safety factors online, then prescribe only when clinically appropriate.

For patients interested in clinician-guided longevity care, Chia offers NAD+ injection or nasal spray, glutathione injection or nasal spray, and sermorelin injection, nasal spray, or tablets. Chia also offers Foundation Longevity, which includes sermorelin injection, NAD+ injection, and glutathione injection, and the Glow protocol, which includes GHK-Cu cream, glutathione injection, and NAD+ injection.

These treatments may have side effects and may not be appropriate for people with certain medical histories, medication interactions, pregnancy, breastfeeding, active cancer concerns, or uncontrolled medical conditions. Because longevity-related uses may be off-label, our providers review risks, goals, and alternatives before deciding whether a prescription is appropriate.

When should you talk with a clinician about mitochondrial testing?

Talk with a clinician if symptoms are severe, progressive, multi-system, or unusual for you. Direct-to-consumer marker interpretation can be misleading because mitochondrial markers overlap with many common conditions 4.

Red flags that need medical evaluation

• New or worsening muscle weakness, exercise intolerance, or episodes of dark urine after exertion
• Seizures, stroke-like episodes, fainting, or unexplained neurologic symptoms
• Unexplained cardiomyopathy, rhythm problems, or repeated high lactate levels
• Vision loss, hearing loss, diabetes, liver disease, or neurologic symptoms in a pattern that affects several family members
• Symptoms that worsen with fasting, illness, anesthesia, or certain medications

Why direct-to-consumer marker interpretation can be misleading

A high or low value can reflect collection problems, exercise, diet, medications, kidney or liver function, inflammation, infection, or another condition. Consensus guidance supports interpreting mitochondrial testing in the full clinical picture rather than using isolated results 4.

Questions to bring to a medical visit

• Do my symptoms involve more than one organ system?
• Could common causes explain my fatigue, weakness, or exercise intolerance first?
• Would basic labs, metabolic labs, genetic testing, or specialist referral be the right next step?
• Are any of my medications or supplements affecting my results?
• If I am considering longevity treatments, what safety factors matter for me?

Keep reading

Longevity

Mitochondrial Repair: What It Means, What Helps, and What Is Still Experimental

Longevity

Mitochondrial Fatigue: What It Means, Symptoms, and What May Help

Longevity

Mitochondrial Replication: How Cells Copy Mitochondria and mtDNA